A new leader has been named at Analogic. Company founder, board chairman, and CEO Bernard M. Gordon announced Jan. 25 that Thomas J. Miller Jr., will assume the role of CEO effective Feb 1. Gordon will remain as board chairman.Gordon, who founded
A new leader has been named at Analogic. Company founder, board chairman, and CEO Bernard M. Gordon announced Jan. 25 that Thomas J. Miller Jr., will assume the role of CEO effective Feb 1. Gordon will remain as board chairman.
Gordon, who founded Analogic in 1969, is an R&D icon, having developed numerous technologies, notably the first high-speed analog-to-digital converter. He was awarded the National Medal of Technology in 1986. Miller has served as president and COO of Analogic for the past 15 months. During this time he developed and began implementing a five-year strategic plan. Prior to joining Analogic, Miller had been president and CEO of Carl Zeiss, Inc., world general manager of Carl Zeiss Medical Group, and group vice president of imaging systems for Siemens Medical Systems' North American operations.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.